BackInitiator Pharma A/S Overview

Initiator Pharma A/S Accounts Payable

Initiator Pharma A/S's accounts payable is $1M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$996999.00
↓ 64.32% YoYΔ $-1.80M vs prior year quarter

Peer trimmed avg / median

Loading

Initiator Pharma A/S Accounts Payable History

Loading

Initiator Pharma A/S vs. peers: Accounts Payable Comparison

Loading

Initiator Pharma A/S Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Initiator Pharma A/S (INIT.ST) FAQ

Initiator Pharma A/S's accounts payable stands at $1M as of June 2026. That compares with $2.8M in the prior-year period — down 64.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Initiator Pharma A/S reported $1M in accounts payable versus $2.8M a year earlier — a 64.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $2.8M in the prior-year period — down 64.3% year over year. Sustained growth in accounts payable can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Initiator Pharma A/S's accounts payable evolved across reporting periods, while the comparison chart places INIT.ST next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, accounts payable is commonly used to spot outliers. Initiator Pharma A/S's reading of $1M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.